Adient (ADNT)
(Real Time Quote from BATS)
$28.95 USD
-0.04 (-0.14%)
Updated Apr 23, 2024 12:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Income Statements
Fiscal Year end for Adient falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 15,395 | 14,121 | 13,680 | 12,670 | 16,526 |
Cost Of Goods | 14,362 | 13,314 | 12,854 | 12,078 | 15,725 |
Gross Profit | 1,033 | 807 | 826 | 592 | 801 |
Selling & Adminstrative & Depr. & Amort Expenses | 554 | 598 | 537 | 558 | 671 |
Income After Depreciation & Amortization | 479 | 209 | 289 | 34 | 130 |
Non-Operating Income | 11 | 60 | 1,461 | -243 | 54 |
Interest Expense | 195 | 215 | 311 | 220 | 182 |
Pretax Income | 295 | 54 | 1,439 | -429 | 2 |
Income Taxes | 0 | 94 | 249 | 57 | 410 |
Minority Interest | 90 | 80 | 82 | 61 | 83 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 295 | -40 | 1,190 | -486 | -408 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 205 | -120 | 1,108 | -547 | -491 |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 819 | 559 | 619 | 366 | 448 |
Depreciation & Amortization (Cash Flow) | 340 | 350 | 330 | 332 | 318 |
Income After Depreciation & Amortization | 479 | 209 | 289 | 34 | 130 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | 95.40 | 94.80 | 95.70 | 93.80 | 93.60 |
Diluted EPS Before Non-Recurring Items | 2.15 | 0.11 | 2.08 | -0.04 | 1.63 |
Diluted Net EPS (GAAP) | 2.15 | -1.27 | 11.58 | -5.83 | -5.25 |
Fiscal Year end for Adient falls in the month of September.
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 3,660.00 | 3,729.00 | 4,055.00 | 3,912.00 |
Cost Of Goods | NA | 3,414.00 | 3,479.00 | 3,753.00 | 3,662.00 |
Gross Profit | NA | 246.00 | 250.00 | 302.00 | 250.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 147.00 | 127.00 | 148.00 | 141.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 99.00 | 123.00 | 154.00 | 109.00 |
Non-Operating Income | NA | 10.00 | -4.00 | 18.00 | -15.00 |
Interest Expense | NA | 44.00 | 46.00 | 49.00 | 59.00 |
Pretax Income | NA | 65.00 | 73.00 | 123.00 | 35.00 |
Income Taxes | NA | 20.00 | -84.00 | 28.00 | 25.00 |
Minority Interest | NA | 25.00 | 22.00 | 22.00 | 25.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 45.00 | 157.00 | 95.00 | 10.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 20.00 | 135.00 | 73.00 | -15.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 93.60 | 94.80 | 94.90 | 95.30 |
Diluted EPS Before Non-Recurring Items | NA | 0.31 | 0.51 | 0.98 | 0.32 |
Diluted Net EPS (GAAP) | NA | 0.21 | 1.41 | 0.77 | -0.16 |